Big Opportunity: India's Third Giant Leap
Here is the latest financial fact sheet of ALEMBIC. For more details, see the ALEMBIC quarterly results and ALEMBIC share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.3 |
No. of shares | m | 256.78 |
1 Week | % | 0.0 |
1 Month | % | 0.0 |
1 Year | % | - |
52 week H/L | Rs | 87.0/56.0 |
No. of Mths Year Ending |
12 Mar-18* |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
ALEMBIC EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 72 | 62 | 65 | 123 | 143 | |
Low | Rs | 34 | 36 | 25 | 32 | 72 | |
Sales per share (Unadj.) | Rs | 4.6 | 4.8 | 2.9 | 2.9 | 3.0 | |
Earnings per share (Unadj.) | Rs | 1.6 | 1.6 | 3.6 | 0.5 | 3.4 | |
Diluted earnings per share | Rs | 1.6 | 1.6 | 3.6 | 0.5 | 3.4 | |
Cash flow per share (Unadj.) | Rs | 1.7 | 1.7 | 3.7 | 0.7 | 3.5 | |
Dividends per share (Unadj.) | Rs | 0.20 | 0.20 | 0.60 | 0.20 | 1.80 | |
Adj. dividends per share | Rs | 0.21 | 0.20 | 0.60 | 0.20 | 1.80 | |
Avg Dividend yield | % | 0.4 | 0.4 | 1.3 | 0.3 | 1.7 | |
Book value per share (Unadj.) | Rs | 40.7 | 47.1 | 55.2 | 89.5 | 97.2 | |
Adj. book value per share | Rs | 42.3 | 47.1 | 55.2 | 89.5 | 97.2 | |
Shares outstanding (eoy) | m | 267.03 | 256.78 | 256.78 | 256.78 | 256.78 | |
Price / Sales ratio | x | 11.4 | 10.2 | 15.6 | 27.0 | 35.3 | |
Avg P/E ratio | x | 33.8 | 30.7 | 12.4 | 143.5 | 32.1 | |
P/CF ratio (eoy) | x | 31.0 | 28.8 | 12.0 | 111.7 | 30.4 | |
Price / Book Value ratio | x | 1.3 | 1.0 | 0.8 | 0.9 | 1.1 | |
Dividend payout | % | 12.8 | 12.5 | 16.6 | 37.1 | 53.6 | |
Avg Mkt Cap | Rs m | 14,133 | 12,608 | 11,523 | 19,868 | 27,643 | |
Total wages/salary | Rs m | 196 | 205 | 208 | 226 | 215 |
ALEMBIC INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,235 | 1,238 | 739 | 735 | 782 | |
Other income | Rs m | 370 | 295 | 935 | 109 | 892 | |
Total revenues | Rs m | 1,606 | 1,533 | 1,675 | 844 | 1,674 | |
Gross profit | Rs m | 111 | 181 | 31 | 104 | 139 | |
Depreciation | Rs m | 38 | 26 | 32 | 39 | 49 | |
Interest | Rs m | 2 | 2 | 3 | 4 | 4 | |
Profit before tax | Rs m | 442 | 447 | 932 | 170 | 979 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 24 | 36 | 1 | 32 | 117 | |
Profit after tax | Rs m | 418 | 411 | 930 | 138 | 862 | |
Gross profit margin | % | 9.0 | 14.6 | 4.2 | 14.2 | 17.8 | |
Effective tax rate | % | 5.4 | 8.0 | 0.1 | 18.8 | 11.9 | |
Net profit margin | % | 33.8 | 33.2 | 125.8 | 18.8 | 110.2 |
ALEMBIC BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,867 | 988 | 1,628 | 1,021 | 1,433 | |
Current liabilities | Rs m | 591 | 488 | 458 | 594 | 678 | |
Net working cap to sales | % | 103.3 | 40.4 | 158.3 | 58.1 | 96.6 | |
Current ratio | x | 3.2 | 2.0 | 3.6 | 1.7 | 2.1 | |
Inventory Days | Days | 2,698 | 2,952 | 5,596 | 10,191 | 10,346 | |
Debtors Days | Days | 747 | 398 | 444 | 686 | 710 | |
Net fixed assets | Rs m | 9,723 | 11,671 | 13,079 | 23,069 | 24,886 | |
Share capital | Rs m | 534 | 514 | 514 | 514 | 514 | |
"Free" reserves | Rs m | 10,324 | 11,572 | 13,667 | 22,457 | 24,452 | |
Net worth | Rs m | 10,858 | 12,085 | 14,180 | 22,970 | 24,966 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 11,590 | 12,658 | 14,707 | 24,090 | 26,320 | |
Interest coverage | x | 262.4 | 207.8 | 324.5 | 48.1 | 252.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.1 | 0.1 | 0.1 | 0 | 0 | |
Return on assets | % | 3.6 | 3.3 | 6.3 | 0.6 | 3.3 | |
Return on equity | % | 3.8 | 3.4 | 6.6 | 0.6 | 3.5 | |
Return on capital | % | 4.1 | 3.7 | 6.6 | 0.8 | 3.9 | |
Exports to sales | % | 1.6 | 2.5 | 2.2 | 1.5 | 2.0 | |
Imports to sales | % | 21.3 | 31.2 | 18.6 | 6.1 | 0.3 | |
Exports (fob) | Rs m | 19 | 30 | 16 | 11 | 16 | |
Imports (cif) | Rs m | 263 | 386 | 138 | 45 | 2 | |
Fx inflow | Rs m | 19 | 30 | 16 | 11 | 16 | |
Fx outflow | Rs m | 264 | 387 | 138 | 45 | 2 | |
Net fx | Rs m | -244 | -357 | -121 | -34 | 13 |
ALEMBIC CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 236 | 215 | 65 | -22 | -177 | |
From Investments | Rs m | -224 | 717 | 567 | -349 | 188 | |
From Financial Activity | Rs m | -27 | -920 | -64 | -154 | -58 | |
Net Cashflow | Rs m | -15 | 12 | 569 | -524 | -47 |
Share Holding
Shareholding as on Dec 2022
|
Company Information
|
CHM: Chirayu Amin | COMP SEC: Drigesh Mittal | YEAR OF INC: 1907 | BSE CODE: 506235 | FV (Rs): 2 | DIV YIELD (%): 3.2 |
Read: ALEMBIC 2021-22 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: AUROBINDO PHARMA CIPLA SUN PHARMA PIRAMAL ENTERPRISES LUPIN
Compare ALEMBIC With: AUROBINDO PHARMA CIPLA SUN PHARMA PIRAMAL ENTERPRISES LUPIN
After opening the day on a positive note, Indian share reversed gains as the session progressed and ended marginally lower.